1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Biotech stocks typically are considered one of Wall Street’s more aggressive sources of growth. These companies spend years and gobs of money to create breakthrough biological treatments and diagnostic...
The fallout in biotech stocks has created risky, but enticing, opportunities.
These biotechnology companies are making important strides in treating many forms of cancer.
More Investing News »